Moyamoya Disease Complicating Ebstein's Anomaly
暂无分享,去创建一个
T. Tanigawa | A. Tsuji | K. Dohi | R. Okamoto | I. Goto | Yuichi Sato
[1] Karen E Schultz,et al. Heart failure in the adult Ebstein patient , 2020, Heart Failure Reviews.
[2] Stephanie Fuller,et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Circulation.
[3] S. Yuan. Ebstein's Anomaly: Genetics, Clinical Manifestations, and Management. , 2017, Pediatrics and neonatology.
[4] A. van der Zwan,et al. Research Progresses in Understanding the Pathophysiology of Moyamoya Disease , 2016, Cerebrovascular Diseases.
[5] C. Meena,et al. Moyamoya Disease with Ebstein Anomaly: an Unusual Co-occurrence , 2014 .
[6] L. Regli,et al. Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[7] L. E. Mitchell,et al. Epidemiology of Ebstein anomaly: Prevalence and patterns in Texas, 1999–2005 , 2011, American journal of medical genetics. Part A.
[8] R. Scott,et al. Moyamoya disease and moyamoya syndrome. , 2009, The New England journal of medicine.
[9] S. Kuroda,et al. Novel epidemiological features of moyamoya disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[10] Christine H. Attenhofer Jost,et al. Ebstein’s Anomaly , 2006, Circulation.
[11] T. Geva,et al. Moyamoya Syndrome Associated With Congenital Heart Disease , 1998, Pediatrics.
[12] J. Boughman,et al. Ebstein's malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infant Study Group. , 1994, Teratology.
[13] A. Yamamoto,et al. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). , 2012, Neurologia medico-chirurgica.